California regulators say 'no' to Adventist Health, St. Joseph Health merger

Photo of two men shaking hands in front of a hospital
California regulators are rejecting a proposed merger between Adventist Health System and St. Joseph Health System. (cunaplus/Shutterstock)

California regulators are rejecting a proposed merger between Adventist Health System and St. Joseph Health System.

The state's Department of Justice (DOJ) sent a letter (PDF) that denied the proposed deal, which would have created a joint operating company with authority over each health system’s facilities in Humboldt, Lake, Mendocino, Napa, Solano, and Sonoma counties. Health system officials submitted a proposal to state officials in June 2018, saying they would improve access to quality healthcare throughout the Northern California region.

RELATED: Ascension's merger talks with Providence St. Joseph end as it pursues new strategic direction

Webinar This Week

Optimizing Healthcare Operational Excellence to Drive Care Transformation

Join us in this webinar to learn how organizations have leveraged modern technology to enable transformative innovation and continuous improvement across their operations resulting in overall cost savings, process optimization, and clinical improvements.

“The California Department of Justice is responsible for ensuring that any proposed sale or transfer of a non-profit health facility protects the health and safety interests of the surrounding community. After careful review we found this proposal falls short of protecting consumers,” said Sean McCluskie, chief deputy to the California attorney general, in a statement.

 

Suggested Articles

Workers’ contributions to their health plan premiums and deductibles increased at a faster rate than wages over the past decade.

The Trump administration released its regulatory agenda that includes estimates on when major rules on drug prices and interoperability will be out

David Feinberg, M.D., head of Google Health, posted a blog post and video Tuesday to directly address growing concerns about the Ascension data deal.